Clinical Trial

Nurse-led Physician-supported Care for Patients With Chronic Kidney Disease and Multimorbidity

Study acronym: INTEGREATCKD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 18, 2024 (before its estimated May 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Chronic kidney disease (CKD) is a prevalent chronic disease and is often intertwined with the management of cardiovascular disease and the optimization of metabolic risk factors. In light of steeply rising rates of end-stage kidney disease (ESKD) and increased healthcare resource utilization by CKD patients, the investigators propose that the role of nurses could be expanded to support the care of CKD patients in the community. A total of 220 patients will be randomized (1:1) to the intervention or control groups (usual care). The intervention entails enrolment into a nurse-led, physician-supported programme (INTEGREAT-CKD), comprising outpatient consultations and community-based ambulatory monitoring and counselling primarily driven by CKD-trained advanced practice nurses (APNs) and healthcare professionals conducted over 6 months. Patient-reported outcomes like health-related quality of life (HRQOL), as measured by EQ-5D and KDQOL, CKD self-management score and CKD health literacy will be assessed at baseline and after 6 months. The primary outcome is CKD self-management. Other secondary outcomes to be assessed and tracked including achievement of clinical targets relevant to slowing down CKD progression, attainment of CKD best practice guidelines as specified in the KDIGO CKD Evaluation and Management guidelines 2020.
Trial Details
NCT Number NCT06372743
Lead Sponsor Alexandra Hospital
Collaborators: National University Hospital, Singapore
Conditions Chronic Kidney Diseases
Enrollment 220 participants
Start Date 2023-11-01
Primary Completion 2025-05-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-04-18